While large genetic testing panels promise to uncover clues about patients’ DNA, a team of researchers from Penn Medicine’s Abramson Cancer Center (ACC)has found that…

Mutations in the BRCA1 and BRCA2 genes account for nearly 25 percent of hereditary breast cancers and most hereditary ovarian cancers, yet a study…

While research has made great strides in recent decades to improve and significantly extend the lives of patients with early breast cancer, the needs of patients…

Findings and Significance: During breast-tissue development, a transcription factor called SLUG plays a role in regulating stem cell function and determines whether breast cells will mature…

A new study reports that sleep efficiency, a ratio of time asleep to time spent in bed, is predictive of survival time for women with…

Mayo Clinic research into whether ultrasounds to detect breast cancer in underarm lymph nodes are less effective in obese women has produced a…

Gene expression profiling tests play a critical role when women with early-stage breast cancer decide whether to have chemotherapy, but many of them do not…

Nearly one-third of breast cancer survivors who were working when they began treatment were unemployed four years later. Women who received chemotherapy were most affected, according to a new study from…

A new study has found that loss of paid employment after a diagnosis of early-stage breast cancer may be common and potentially related to the…

Purdue University researchers have developed a way to detect and measure cancer levels in a living cell by using tiny gold particles with tails…

Women whose mammograms suggest possible breast cancer that is eventually ruled out experience slightly increased anxiety, but that doesn’t necessarily affect their overall health, according to a new study.

What’s…

Scientists at the Salk Institute have uncovered details into a surprising - and crucial - link between brain development and a gene whose mutation is tied…

A mid-stage trial of Puma Biotechnology’s experimental drug neratinib showed that it was more effective, given before surgery, than Herceptin, the Roche drug commonly used in women…

Unique laboratory testing during breast cancer lumpectomies to make sure surgeons remove all cancerous tissue spares patients the need for a repeat lumpectomy in roughly 96 percent of cases at…

Women who took clomiphene citrate (brand name Clomid) or gonadotropins as a part of fertility treatment did not experience an increased risk for breast cancer over 30…

Results of EORTC trial 10994 appearing in the Annals of Oncology show that pathological complete response after neoadjuvant chemotherapy is an independent predictive factor of favorable clinical outcomes…

Population-based screening with full-field digital mammography (FFDM) is associated with lower recall and biopsy rates than screen film mammography (SFM), suggesting that FFDM may reduce the number of diagnostic…

A derivative of vitamin A, known as retinoic acid, found abundantly in sweet potato and carrots, helps turn pre-cancer cells back to normal healthy breast cells,…

The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related,…

Faster and cheaper DNA sequencing techniques will likely improve care for patients with breast cancer but also create challenges for clinicians as they counsel…

Black and Latina breast cancer patients were more than twice as likely as white women to have lingering medical debt and to skip treatments because of costs, according…

Women who have their breasts removed because of cancer may benefit from receiving radiation if they still have traces of cancer in their lymph nodes, suggests a new analysis.

A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise in treating breast cancer that has spread to the liver when no other treatment options…

Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their…

Improvements in treatment, as well as enhanced access to care, underlie the sustained decreases in breast cancer mortality seen in 30 European countries [1] from 1989 to 2010. But there…